Effectiveness of LH-RH agonist for bone metastases of breast cancer--report of a case
Kudoh, S.; Kawamura, H.; Suzuki, Y.; Matsuzaki, M.; Nishina, M.; Tsukamoto, M.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(6): 787-790
1996
ISSN/ISBN: 0385-0684 PMID: 8645031 Document Number: 464292
A 44-year-old premenopausal woman with bone metastases of breast cancer was initially treated with systemic chemotherapy (CEF) and radiation therapy after standard mastectomy. However, progressive change of bone metastases with elevation of tumor markers (CEA, NCC-ST 439) was detected, so continuous administration of LH-RH agonist and combination chemotherapy (CEF) were conducted. Subsequently, complete objective regression was attained after 40 weeks.